HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

Tariq Sethi

Ulf Nilsson

Hakon Leffler

Hans Schambye

HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Metric
Company Name	HBM Healthcare Investments AG
Symbol	HBMN
MSH ID	COM:HBMHEALTHCARE
Market	STOCKS
Sector
Industry
Country	CH
Stage
Employee Count
Website	hbmhealthcare.com
LinkedIn	hbm-healthcare-investments-ag
Founders

Metric
Market Cap	13.05M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.57M
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.40M
EBITDA	592.76K
Operating Income	592.76K
Net Income	-1.23M
EPS	-0.18
Diluted EPS	-0.18
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	1.23
Operating Profit Margin	1.01
EBITDA Margin	0.38
Net Profit Margin	1.01
Return on Equity	0.02
Return on Assets	0.02
Return on Capital Employed	0.01

COM:HBMHEALTHCARE

Galecto, Inc.

Last Close

175.60

25/11 09:19

Market Cap

11.45M

Beta: -

Volume Today

829

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-6.76
P/B Ratio	0.75
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.05K
EV Multiple	-11.54

Metric
Days Sales Outstanding	-0.13
Days Payables Outstanding
Days Inventory Outstanding	0.00
Operating Cycle	15.88
Cash Conversion Cycle	15.88
Asset Turnover	0.02

Metric
Operating Cash Flow	-1.94M
Free Cash Flow	-1.94M
Cash Flow to Debt	-0.01
Operating Cash Flow/Sales	0.01
Free Cash Flow Yield	-0.00

Metric
Cash & Equivalents	11.66M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization	0.12
Debt to Assets	0.05
Current Ratio	0.04
Quick Ratio	3.10

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue	-0.01